The epidemiology of human papillomavirus infection and cervical cancer

Disease Markers

Volumn 23, Issue 4, 2007, Pages 213-227

  Bosch, F Xavier ^a   De Sanjosé, Silvia ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Cervical cancer; Epidemiology; HPV; Human papillomavirus

Indexed keywords

ORAL CONTRACEPTIVE AGENT; VIRUS DNA;

ADENOCARCINOMA; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CHLAMYDIA TRACHOMATIS; CIGARETTE SMOKING; DISEASE ASSOCIATION; DNA FINGERPRINTING; ENVIRONMENTAL FACTOR; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORAL CONTRACEPTION; PAPILLOMATOSIS; PARITY; PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

CHLAMYDIA TRACHOMATIS; HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 34347335810     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/914823     Document Type: Review

References (34)

1. T. Iftner and L.L. Villa, Chapter 12: Human papillomavirus technologies, J Natl Cancer Inst Monogr (2003), 80-88.
2. G.M. Clifford, S. Gallus, R. Herrero, N. Munoz, P.J. Snijders, S. Vaccarella, P.T. Anh, C. Ferreccio, N.T. Hieu, E. Matos, M. Molano, R. Rajkumar, G. Ronco, S. de Sanjose, H.R. Shin, S. Sukvirach, J.O. Thomas, S. Tunsakul, C.J. Meijer and S. Franceschi, Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis, Lancet 366 (2005), 991-998.
3. N. Munoz, F. Mendez, H. Posso, M. Molano, A.J. van Den Brule, M. Ronderos, C. Meijer and A. Munoz, Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results, J Infect Dis 190 (2004), 2077-2087.
4. M.J. Khan, P.E. Castle, A.T. Lorincz, S. Wacholder, M. Sherman, D.R. Scott, B.B. Rush, A.G. Glass and M. Schiffman, The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice, J Natl Cancer Inst 97 (2005), 1072-1079.
5. S.K. Kjaer, B. Chackerian, A.J.C. van der Brule, E.I. Svare, G. Paull, J.M.M. Walboomers, J.T. Schiller, J.E. Bock, M.E. Sherman, D.R. Lowy and C.J.L.M. Meijer, High-Risk Human Papillomavirus Is Sexually Transmitted: Evidence from a Follow-up Study of Virgins Starting Sexual Activity (Intercourse), Cancer Epidemiol Biomark Prev 10 (2001), 101-106.
6. X. Castellsague, A. Ghaffari, R.W. Daniel, F.X. Bosch, N. Munoz and K.V. Shah, Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia, J Infect Dis 176 (1997), 353-361.
7. F.X. Bosch, X. Castellsagué, N. Muñoz, S. de Sanjosé, A.M. Ghaffari, L.C. González, M. Gili, I. Izarzugaza, P. Viladiu, C. Navarro, A. Vergara, N. Ascunce, E. Guerrero and K.V. Shah, Male sexual behavior and Human Papillomavirus DNA: key risk factors for cervical cancer in Spain, J Natl Cancer Inst 88(15) (1996), 1060-1067.
8. N. Muñoz, X. Castellsagué, F.X. Bosch, L. Tafur, S. de Sanjosé, N. Aristizabal, A.M. Ghaffari and K.V. Shah, Difficulty in Elucidating the Male Role in Cervical Cancer in Colombia, a High-Risk Area for the Disease, J Natl Cancer Inst 88(15) (1996), 1068-1075.
9. S. de Sanjose, F.X. Bosch, I. Valls, M.P. Canadas, X. Castellsague, B. Lloveras and K.V. Shah, Prevalence of HPV cervical infections among imprisoned women in Barcelona, Spain, Sex Transm Infect 76 (2000), 58.
10. S.K. Kjaer, E.I. Svare, A.M. Worm, J.M. Walboomers, C.J. Meijer and A.J. van Den Brule, Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity, Sex Transm Dis 27 (2000), 438-445.
11. X. Castellsague, F.X. Bosch, N. Munoz, C.J. Meijer, K.V. Shah, S. de Sanjose, J. Eluf-Neto, C.A. Ngelangel, S. Chichareon, J.S. Smith, R. Herrero, V. Moreno and S. Franceschi, Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners, N Engl J Med 346 (2002), 1105-1112.
12. J. Smith, R. Herrero, K. Erles, D. Grimm, N. Muñoz, F.X. Bosch, L. Tafur, K.V. Shah and J.R. Schlehofer, Adeno-associated virus seroposivility and HPV-induced cervical cancer in Spain and Colombia, Int J Cancer 94 (2001), 520-526.
13. M.C. Bleeker, C.J. Hogewoning, F.J. Voorhorst, A.J. van Den Brule, P.J. Snijders, T.M. Starink, J. Berkhof and C.J. Meijer, Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia, Int J Cancer 107 (2003), 804-810.
14. S. Franceschi, X. Castellsague, L. dal Maso, J.S. Smith, M. Plummer, C. Ngelangel, S. Chichareon, J. Eluf-Neto, K.V. Shah, P.J. Snijders, C.J. Meijer, F.X. Bosch and N. Munoz, Prevalence and determinants of human papillomavirus genital infection in men, Br J Cancer 86 (2002), 705-711.
15. X. Castellsague, R.W. Peeling, S. Franceschi, S. de Sanjose, J.S. Smith, G. Albero, M. Diaz, R. Herrero, N. Munoz and F.X. Bosch, Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men, Am J Epidemiol 162 (2005), 907-916.
16. C. Munk, E.I. Svare, P. Poll, J.E. Bock and S. Krüger Kjaer, History of Genital Warts in 10,838 Women 20 to 29 Years of Age From the General Population, Sex Transm Dis 24(10) (1997), 567-572.
17. C.J. Lacey, Therapy for genital human papillomavirus-related disease, J Clin Virol 32(Suppl 1) (2005), S82-S90.
18. F.X. Bosch and T. Iftner, The Aetiology of Cervical Cancer, Sheffield, UK: NHS Cervical Screening Programme, 2005.
19. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Cervix Cancer Screening. Lyon: IARC Press, 2005.
20. F.X. Bosch, A. Lorincz, N. Muñoz, C.J.L.M. Meijer and K.V. Shah, The causal relation between human papillomavirus and cervical cancer, J Clin Pathol 55 (2002), 244-265.
21. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman and K.V. Shah, Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group, J Natl Cancer Inst 87 (1995), 796-802.
22. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer and N. Munoz, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol 189 (1999), 12-19.
23. X. Castellsague, M. Diaz, S. de Sanjose, N. Munoz, R. Herrero, S. Franceschi, R.W. Peeling, R. Ashley, J.S. Smith, P.J. Snijders, C.J. Meijer and F.X. Bosch, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention, J Natl Cancer Inst 98 (2006), 303-315.
24. H.D. Strickler, J.M. Palefsky, K.V. Shah, K. Anastos, R.S. Klein, H. Minkoff, A. Duerr, L.S. Massad, D.D. Celentano, C. Hall, M. Fazzari, S. Cu-Uvin, M. Bacon, P. Schuman, A.M. Levine, A.J. Durante, S. Gange, S. Melnick and R.D. Burk, Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women, J Natl Cancer Inst 95 (2003), 1062-1071.
25. G.M. Clifford, J.S. Smith, M. Plummer, N. Muñoz and S. Franceschi, Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis, Br J Cancer 88 (2003), 63-73.
26. N. Munoz, F.X. Bosch, X. Castellsague, M. Diaz, S. de Sanjose, D. Hammouda, K.V. Shah and C.J. Meijer, Against which human papillomavirus types shall we vaccinate and screen? The international perspective, Int J Cancer 111 (2004), 278-285.
27. N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders and C.J. Meijer, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med 348 (2003), 518-527.
28. M. Kyrgiou, G. Koliopoulos, P. Martin-Hirsch, M. Arbyn, W. Prendiville and E. Paraskevaidis, Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis, Lancet 367 (2006), 489-498.
29. N. Munoz, S. Franceschi, C. Bosetti, V. Moreno, R. Herrero, J.S. Smith, K.V. Shah, C.J. Meijer and F.X. Bosch, Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study, Lancet 359 (2002), 1093-1101.
30. X. Castellsague and N. Munoz, Chapter 3: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking, J Natl Cancer Inst Monogr (2003), 20-28.
31. IARC. IARC Monographs. Vol. 38. Tobacco Smoking and Tobacco Smoke. 2002.
32. J.M. Palefsky and E.A. Holly, Chapter 6: Immunosuppression and co-infection with HIV, J Natl Cancer Inst Monogr (2003), 41-46.
33. J.S. Smith, R. Herrero, C. Bosetti, N. Munoz, F.X. Bosch, J. Eluf-Neto, X. Castellsague, C.J. Meijer, A.J. van Den Brule, S. Franceschi and R. Ashley, Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer, J Natl Cancer Inst 94 (2002), 1604-1613.
34. J.S. Smith, N. Munoz, R. Herrero, J. Eluf-Neto, C. Ngelangel, S. Franceschi, F.X. Bosch, J.M. Walboomers and R.W. Peeling, Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines, J Infect Dis 185 (2002), 324-331.